Published in Vaccine Weekly, March 15th, 1999
The test, targeting the p7 protein found on the HIV type 1 virus, has the potential to replace existing methods of diagnosis and determining the effectiveness of new AIDS vaccines and therapies - offering better accuracy and efficiency at substantially reduced cost. The test is being developed to diagnose HIV-1 infection, to measure virus replication in patients,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.